Skip to content
Telehealth Graded
State guide

Mississippi Medicaid and GLP-1s

Mississippi is one of the states that still pays for a GLP-1 because you are obese, full stop — no cardiac event, no sleep study, no diabetes. Saxenda and Wegovy start at 12, Foundayo and Zepbound at 18, and approvals run a year. The renewal test is the interesting part: the state looks at the pharmacy claims as well as the weight.

Every source on this page was read first-hand in September 2026, and each one below carries the date printed on the document itself.

1
document cited
9
sourced facts
1
primary source

What changed, and what the document says

  1. Coverage for the diagnosis itself

    Covered

    Mississippi says it in the first line of its criteria, and picks winners rather than covering the class.

    While there are various medications with differing mechanisms of action that are FDA-approved to treat obesity, Mississippi Medicaid covers select agents for this condition.

    Mississippi Division of Medicaid, Pharmacy Prior Authorization Unit07/01/2026

  2. Twelve and up for two of them

    Covered

    Adolescents get the semaglutide and liraglutide products, on the preferred tier.

    Saxenda or Wegovy for ages 12 years and older

    Mississippi Division of Medicaid, Pharmacy Prior Authorization Unit07/01/2026

  3. Eighteen and up for the other two

    Covered

    Foundayo on this list makes Mississippi one of the first states to put an oral GLP-1 in an obesity policy.

    Foundayo and Zepbound for ages 18 years and older

    Mississippi Division of Medicaid, Pharmacy Prior Authorization Unit07/01/2026

  4. A full year to start

    Covered

    Twelve months, against three in Tennessee and six on most of the exception routes elsewhere.

    Initial Authorization: 12 Months

    Mississippi Division of Medicaid, Pharmacy Prior Authorization Unit07/01/2026

  5. One drug at a time

    Conditions apply

    Stated twice in two sentences, so there is no reading it as a preference.

    Coverage of select medications for the treatment of obesity will be limited to only one covered product at a given time. Mississippi Medicaid will not cover concurrent use of two or more agents for the treatment of obesity.

    Mississippi Division of Medicaid, Pharmacy Prior Authorization Unit07/01/2026

  6. Not during pregnancy or breastfeeding

    Conditions apply

    A flat carve-out, written into the coverage rule rather than left to the label.

    Mississippi Medicaid does not cover medications for treatment of obesity during pregnancy or for mothers who are breast-feeding.

    Mississippi Division of Medicaid, Pharmacy Prior Authorization Unit07/01/2026

  7. Two drugs excluded over rebates

    Context

    The reason given isn't clinical. Two anti-obesity products are off the list because of a federal rebate agreement.

    Contrave – This agent is not rebated through CMS.

    Mississippi Division of Medicaid, Pharmacy Prior Authorization Unit07/01/2026

  8. Renewal counts the refills

    Conditions apply

    The state reads the claims history, and it has put a number on what counts as sticking with it.

    Adherence is defined as at least 9 claims in the past year.

    Mississippi Division of Medicaid, Pharmacy Prior Authorization Unit07/01/2026

  9. And the scale, or the growth chart

    Conditions apply

    Adults are measured on 5 percent. Children are measured against their own baseline BMI.

    Has the member achieved or maintained a weight loss of 5% or greater from baseline weight?

    Mississippi Division of Medicaid, Pharmacy Prior Authorization Unit07/01/2026

Which of these companies serve Mississippi?

Of the 159 companies we grade, 19 publish a list of the states they are licensed in. We checked 137 more and found no such list on any page we read; 3 we have not checked either way.

6 of those lists name Mississippi: Gala Health, Care Bare Rx, Vita Bella, Ways2Well, TeleClinic and Tyde Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Sources

Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026, the same session as the rest of this page.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.